Bonesupport
365
SEK
+5,19 %
BONEX
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Mindre end 1K følgere
+5,19%
-8,8%
-5,64%
+10,74%
+36,5%
+80,69%
+805,71%
+855,5%
+1.040,63%
Bone Support is active in medical technology. The company develops and commercializes injectable bioceramic bone graft substitutes that are transformed into the patient's bone and have the ability to release drugs. The company's bone graft substitutes are based on the technology platform Cerament. At present, the company conducts ongoing clinical studies. The company has sales in Europe and North America and is headquartered in Lund, Sweden.
Læs mereMarkedsværdi
24,37 mia. SEK
Aktieomsætning
47,4 mio. SEK
Omsætning
591,08 mio.
EBIT %
2,36 %
P/E
96,82
Udbytteafkast, %
-
Finanskalender
25.2
2025
Årsrapport '24
24.4
2025
Delårsrapport Q1'25
27.5
2025
Generalforsamling '25
ViserAlle indholdstyper
CERAMENT® G AND CERAMENT® V contributes to improved survival rates
Change in BONESUPPORT’s Nomination Committee ahead of the 2025 Annual General Meeting following a change in ownership
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools